Stablecoin Development Corp (SDEV) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2026-04-02
9:44 pm
Purchase		2026-03-3113DNOVABAY PHARMACEUTICALS INC CO
NBY		R01 Fund LP15,480,044
58.100%		4,118,828increase
(+36.25%)		Filing
History
2026-03-11
1:27 pm
Purchase		2025-10-2013DNOVABAY PHARMACEUTICALS INC CO
NBY		Poplar Point Capital Management LLC1,020,300
0.810%		816,240increase
(+400.00%)		Filing
History
2026-01-29
7:38 pm
Purchase		2025-10-2113DNOVABAY PHARMACEUTICALS INC CO
NBY		Lazar David E.1,277,600
4.990%		977,184increase
(+325.28%)		Filing
History
2026-01-21
8:12 pm
Unchanged		2026-01-1613DNOVABAY PHARMACEUTICALS INC CO
NBY		Framework Ventures IV L.P.11,361,216
45.000%		0
(Unchanged)		Filing
History
2026-01-21
8:11 pm
Unchanged		2026-01-1613DNOVABAY PHARMACEUTICALS INC CO
NBY		R01 Fund LP11,361,216
45.000%		0
(Unchanged)		Filing
History
2025-10-20
9:42 pm
Purchase		2025-10-1613DNOVABAY PHARMACEUTICALS INC CO
NBY		R01 Fund LP11,361,216
45.100%		11,128,393increase
(+4779.77%)		Filing
History
2025-10-20
9:42 pm
Purchase		2025-10-1613DNOVABAY PHARMACEUTICALS INC CO
NBY		Framework Ventures IV L.P.11,361,216
45.100%		11,128,393increase
(+4779.77%)		Filing
History
2025-10-17
5:29 pm
Purchase		2025-10-1613DNOVABAY PHARMACEUTICALS INC CO
NBY		Lazar David E.300,416
19.990%		60,406increase
(+25.17%)		Filing
History
2025-10-17
5:10 pm
Unchanged		2025-10-1513DNOVABAY PHARMACEUTICALS INC CO
NBY		Poplar Point Capital Management LLC204,060
17.520%		0
(Unchanged)		Filing
History
2025-10-15
8:29 pm
Purchase		2025-10-0913DNOVABAY PHARMACEUTICALS INC CO
NBY		R01 Fund LP232,823
16.200%		232,823increase
(New Position)		Filing
History
2025-10-15
8:28 pm
Purchase		2025-10-0913DNOVABAY PHARMACEUTICALS INC CO
NBY		Framework Ventures IV L.P.232,823
16.200%		232,823increase
(New Position)		Filing
History
2025-09-04
7:21 pm
Unchanged		2025-09-0313DNOVABAY PHARMACEUTICALS INC CO
NBY		Poplar Point Capital Management LLC204,060
17.520%		0
(Unchanged)		Filing
History
2025-08-26
4:11 pm
Purchase		2025-08-1913DNOVABAY PHARMACEUTICALS INC CO
NBY		Lazar David E.240,010
19.990%		240,010increase
(New Position)		Filing
History
2025-06-04
12:46 pm
Purchase		2025-06-0313DNOVABAY PHARMACEUTICALS INC CO
NBY		Poplar Point Capital Management LLC204,060
17.540%		9,729increase
(+5.01%)		Filing
History
2025-05-15
09:00 am
Purchase		2025-03-3113GNOVABAY PHARMACEUTICALS INC CO
NBY		Poplar Point Capital Management LLC194,331
16.710%		70,194increase
(+56.55%)		Filing
History
2025-02-06
6:30 pm
Purchase		2025-01-3113GNOVABAY PHARMACEUTICALS INC CO
NBY		Poplar Point Capital Management LLC124,137
12.700%		48,478increase
(+64.07%)		Filing
History
2025-01-10
6:06 pm
Purchase		2024-12-3113GNOVABAY PHARMACEUTICALS INC CO
NBY		Poplar Point Capital Management LLC75,659
7.700%		75,659increase
(New Position)		Filing
History
2024-11-08
5:31 pm
Sale		2024-09-3013GNOVABAY PHARMACEUTICALS INC CO
NBY		Hudson Bay Capital Management LP0
0.000%		-4,107decrease
(Position Closed)		Filing
History
2024-02-14
2:52 pm
Purchase		2023-12-3113GNOVABAY PHARMACEUTICALS INC CO
NBY		ARMISTICE CAPITAL LLC2,177
4.990%		1,081increase
(+98.63%)		Filing
History
2024-02-13
5:17 pm
Purchase		2023-12-3113GNOVABAY PHARMACEUTICALS INC CO
NBY		Altium Capital Management LLC3,626
4.990%		3,626increase
(New Position)		Filing
History
Goto 0, 1, Next